Back

A Multicenter, Randomized-Controlled, Blinded Trial of Drug-Eluting vs. Bare Metal Stents in De Novo Saphenous Vein Graft Lesions

26 August 2017 (13:42 - 13:55)
Organised by:
Congress Presentation Part of: Late-Breaking Science in PCI 1 PCI / stents: devices and technique ESC Premium Access ESC Congress 2017

About the speaker

Photo
Mr Emmanouil Brilakis

Minneapolis Heart Institute Foundation, Minneapolis (United States of America)

6 More presentations in this session

Presentation thumbnail
Comparison of titanium-nitride-oxide-coated versus everolimus-eluting stents in acute coronary syndrome
Doctor P. Tonino (Eindhoven, NL)
Slides Video
Presentation thumbnail
Early strut coverage in patients receiving new-generation drug-eluting stents and its implications for dual antiplatelet therapy: a randomized controlled trial
Professor M. Hong (Seoul, KR)
Slides Video
Presentation thumbnail
Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention and Survival in Patients with Type 1 Diabetes Mellitus
Doctor M. Holzmann (Stockholm, SE)
Slides Video
Presentation thumbnail
Five-year Outcome of a Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer
Doctor M. Natsuaki (Saga, JP)
Slides Video
Presentation thumbnail
Clinical outcomes of State-of-the-Art percutaneous coronary revascularization in patients with de novo three vessel disease: Results of the SYNTAX II trial.
Professor J. Escaned (Madrid, ES)
Slides Video

Access the full session

Session thumbnail
Late-Breaking Science in PCI 1

The Event

Event poster

ESC Congress 2017

26 August 2017 13:42 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources